DpC

CAS No. 1382469-39-7

DpC( —— )

Catalog No. M36990 CAS No. 1382469-39-7

DPC is an antitumor compound that inhibits cancer cell proliferation with an IC50 of 0.007-0.096 μM.DPC is involved in a variety of anticancer therapies and can be used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 Get Quote
5MG 65 Get Quote
10MG 103 Get Quote
25MG 204 Get Quote
50MG 327 Get Quote
100MG 473 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DpC
  • Note
    Research use only, not for human use.
  • Brief Description
    DPC is an antitumor compound that inhibits cancer cell proliferation with an IC50 of 0.007-0.096 μM.DPC is involved in a variety of anticancer therapies and can be used in cancer research.
  • Description
    DpC is an anti-tumor agent. DpC inhibits cancer cell proliferation (IC50: 0.007-0.096 M). DpC synergizes with multiple anti-cancer therapeutics.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1382469-39-7
  • Formula Weight
    353.48
  • Molecular Formula
    C19H23N5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (176.81 mM; Ultrasonic )
  • SMILES
    C(=NNC(N(C)C1CCCCC1)=S)(C2=CC=CC=N2)C3=CC=CC=N3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dharmasivam M, et al. The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells. Biochim Biophys Acta Gen Subj. 2022 Aug;1866(8):130152.?
molnova catalog
related products
  • Endo-1,4-β-xylanase

    Endo-1,4-β-xylanase (Xylanase), a glycoside hydrolase enzyme that degrades arabinoxylan (AX), is commonly utilized in biochemical research. It specifically hydrolyzes the β-xylosidic bonds linking two d-xylopyranosyl residues in a β-(1,4) configuration .

  • Kras4B G12D-IN-1

    Kras4B G12D-IN-1 is an anticancer agent that functions as an inhibitor of the Kras4B G12D protein. It effectively reduces the expression of Kras protein in mouse embryonic fibroblasts (MEFs) harboring the Kras4B G12D mutation.

  • 2-Fluoroadenosine

    2-Fluoroadenosine is a potent inhibitor of lymphocyte-mediated cytolysis.